News

Wegovy maker Novo's profit warning triggers $70 billion share rout
Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...
C-suite shuffles ripple through pharma
In May, the Danish pharma said CEO Lars Fruergaard Jørgensen would step down, following a turn in the obesity market. While Novo was the star of the emerging weight loss and diabetes market through ...
Novo Lifer Takes Job of Reviving Europe’s Weight-Loss Superstar
Maziar Mike Doustdar spent more than three decades quietly climbing the ranks of Novo Nordisk A/S, from office clerk through ...
The Copenhagen Post1d
An international is the new CEO of Danish largest company: “I have embraced the Danish spirit, but we know no borders”
It’s not unusual for a non-national to be CEO, executive director, or president of a company in a country. “C-level” positions and top management roles are often international. However, when the ...
Devdiscourse1d
Pharma Industry Shaken: New Leadership and Tariff Challenges
Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...